Citigroup
IDXX icon

Citigroup’s Idexx Laboratories IDXX Stock Holding History

Citigroup’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$165K – 7512
2020
Q2 		$165K Sell
500
-300
-38% -$86.9K ﹤0.01% 5169
2020
Q1 		$194K Sell
800
-2,200
-73% -$574K ﹤0.01% 4766
2019
Q4 		$784K Sell
3,000
-2,100
-41% -$553K ﹤0.01% 4010
2019
Q3 		$1.39M Sell
5,100
-1,500
-23% -$417K ﹤0.01% 3279
2019
Q2 		$1.82M Buy
6,600
+3,200
+94% +$788K ﹤0.01% 2972
2019
Q1 		$760K Buy
3,400
+1,900
+127% +$392K ﹤0.01% 3709
2018
Q4 		$279K Sell
1,500
-3,000
-67% -$615K ﹤0.01% 4695
2018
Q3 		$1.12M Sell
4,500
-2,800
-38% -$680K ﹤0.01% 3364
2018
Q2 		$1.59M Buy
7,300
+2,300
+46% +$474K ﹤0.01% 2898
2018
Q1 		$957K Buy
5,000
+100
+2% +$18.5K ﹤0.01% 3285
2017
Q4 		$766K Buy
4,900
+4,000
+444% +$630K ﹤0.01% 3618
2017
Q3 		$140K Sell
900
-100
-10% -$15.8K ﹤0.01% 5287
2017
Q2 		$161K Sell
1,000
-2,200
-69% -$357K ﹤0.01% 4966
2017
Q1 		$495K Sell
3,200
-200
-6% -$27.6K ﹤0.01% 3878
2016
Q4 		$399K Buy
+3,400
New +$388K ﹤0.01% 4620

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's IDXX Position: Q1 2026 in Review

Citigroup increased its Idexx Laboratories (IDXX) stake by 2.8% in Q1 2026, buying an estimated $2.1M and bringing the position to 120,283 shares worth $67.6M. The position accounts for 0.03% of the portfolio, ranked #535.

Citigroup first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $92.3M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Citigroup held 120,283 shares of Idexx Laboratories worth $67.6M as of Q1 2026.
  • Citigroup bought 3,276 Idexx Laboratories shares in Q1 2026, an estimated $2.1M.
  • Idexx Laboratories made up 0.03% of Citigroup's portfolio in Q1 2026, its #535 holding.
  • Citigroup first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Idexx Laboratories position peaked at $92.3M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.